Cell-engineering company, MaxCyte, Inc., announced it will acquire SeQure Dx, which focuses on editing assessment services for cell and gene therapies, for $4.5 million. The all-cash deal includes ...

After Sam Altman rejected Elon Musk's bid to buy OpenAI, he has been making headlines for his comments. Musk wanted to take over OpenAI for $97 billion. Here is the full story in 5 points.

After one grocery operator departed the building following the flood of July 2023, and an attempt to secure another operator ...

The Dallas Mavericks may head to the buyout market in hopes of slightly easing the loss of superstar Luka Doncic.

Recent studies suggest a majority of mergers fail. Two tenured professors identified the potential pitfalls and keys to ...

Ryan Stokes is now ready to prove the strength of the industrial conglomerate SGH that he’s been quietly building for more ...